SCHEMBL10062059

SCHEMBL10062059

O=C(NCCO)NCCCCCCNC(=O)NCCO

nearest known ligand 0.61

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 7/20 0.61
PRMT1 Q99873 1/20 0.58
KDM4E B2RXH2 1/20 0.48
MAPK1 P28482 1/20 0.48
HIF1A Q16665 1/20 0.48
ALDH1A1 P00352 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
NAAA Q02083 1/20 0.45
EPHX2 P34913 5/20 0.44
MEN1 O00255 1/20 0.44
USP2 O75604 1/20 0.44
MAPT P10636 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL194187 0.89 EPHX1 (0.48) EPHX1PRMT1ALDH1A1EPHX2MEN1
SCHEMBL31455546 0.89 EPHX1 (0.61) EPHX1PRMT1KDM4EMAPK1HIF1A
SCHEMBL6824758 0.89 EPHX1 (0.61) EPHX1PRMT1KDM4EMAPK1HIF1A
SCHEMBL31455527 0.89 EPHX1 (0.61) EPHX1PRMT1KDM4EMAPK1HIF1A
SCHEMBL17379956 0.89 EPHX1 (0.61) EPHX1PRMT1KDM4EMAPK1HIF1A
SCHEMBL12495236 0.89 EPHX1 (0.83) EPHX1NAAAEPHX2
SCHEMBL8342138 0.89 EPHX1 (0.83) EPHX1NAAAEPHX2
SCHEMBL1956274 0.89 EPHX1 (0.50) EPHX1PRMT1KDM4EMAPK1HIF1A
SCHEMBL10580617 0.89 EPHX1 (0.83) EPHX1NAAAEPHX2
SCHEMBL10578502 0.89 EPHX1 (0.83) EPHX1NAAAEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110475840-B Liquid crystal aligning agent composition, method for producing liquid crystal alignment film, and liquid crystal display device 株式会社LG化学 2023-04-18 CN disclosed
US-11592713-B2 Liquid crystal aligning agent composition, method for preparing liquid crystal alignment film using same, and liquid crystal alignment film and liquid crystal display device using same LG CHEM, LTD. (KR) 2023-02-28 US disclosed
US-11592713-B2 Liquid crystal aligning agent composition, method for preparing liquid crystal alignment film using same, and liquid crystal alignment film and liquid crystal display device using same LG CHEM, LTD. (KR) 2023-02-28 US disclosed
US-10945824-B2 Mechanism for applying high radial force in less-elastic medical devices COOK MEDICAL TECHNOLOGIES LLC (US) 2021-03-16 US disclosed
EP-3575381-B1 LIQUID CRYSTAL ALIGNING AGENT COMPOSITION, METHOD FOR MANUFACTURING LIQUID CRYSTAL ALIGNING FILM USING SAME, LIQUID CRYSTAL ALIGNING FILM USING SAME, AND LIQUID CRYSTAL DISPLAY DEVICE LG CHEMICAL LTD (KR) 2020-12-30 EP disclosed
EP-3575381-B1 LIQUID CRYSTAL ALIGNING AGENT COMPOSITION, METHOD FOR MANUFACTURING LIQUID CRYSTAL ALIGNING FILM USING SAME, LIQUID CRYSTAL ALIGNING FILM USING SAME, AND LIQUID CRYSTAL DISPLAY DEVICE LG CHEMICAL LTD (KR) 2020-12-30 EP disclosed
US-20200392409-A1 LIQUID CRYSTAL ALIGNING AGENT COMPOSITION, METHOD FOR PREPARING LIQUID CRYSTAL ALIGNMENT FILM USING SAME, AND LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE USING SAME LG CHEM, LTD. (KR) 2020-12-17 US disclosed
US-20200392409-A1 LIQUID CRYSTAL ALIGNING AGENT COMPOSITION, METHOD FOR PREPARING LIQUID CRYSTAL ALIGNMENT FILM USING SAME, AND LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE USING SAME LG CHEM, LTD. (KR) 2020-12-17 US disclosed
EP-3575381-A1 LIQUID CRYSTAL ALIGNING AGENT COMPOSITION, METHOD FOR MANUFACTURING LIQUID CRYSTAL ALIGNING FILM USING SAME, LIQUID CRYSTAL ALIGNING FILM USING SAME, AND LIQUID CRYSTAL DISPLAY DEVICE LG CHEM, LTD. (KR) 2019-12-04 EP disclosed
EP-3575381-A1 LIQUID CRYSTAL ALIGNING AGENT COMPOSITION, METHOD FOR MANUFACTURING LIQUID CRYSTAL ALIGNING FILM USING SAME, LIQUID CRYSTAL ALIGNING FILM USING SAME, AND LIQUID CRYSTAL DISPLAY DEVICE LG CHEM, LTD. (KR) 2019-12-04 EP disclosed
US-20190015189-A1 MECHANISM FOR APPLYING HIGH RADIAL FORCE IN LESS-ELASTIC MEDICAL DEVICES WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT 2019-01-17 US disclosed
US-10123863-B2 Mechanism for applying high radial force in less-elastic medical devices COOK MEDICAL TECHNOLOGIES LLC (US) 2018-11-13 US disclosed
US-20150272752-A1 MECHANISM FOR APPLYING HIGH RADIAL FORCE IN LESS-ELASTIC MEDICAL DEVICES WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT 2015-10-01 US disclosed
US-8137700-B2 Main chain acid-degradable polymers for the delivery of bioactive materials U.S. DEPARTMENT OF ENERGY (US) 2012-03-20 US disclosed
US-20090220615-A1 Main Chain Acid-Degradable Polymers for the Delivery of Bioactive Materials THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2009-09-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090220615-A1 Main Chain Acid-Degradable Polymers for the Delivery of Bioactive Materials CTSA, GAA, CTSB EPHX1 706/4885PRMT1 4812/4885KDM4E 3927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.